secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2026-01-16T23:59:59+00:00
Accession:  0001640334-26-000109
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences receives Nasdaq delisting notice for missing annual meeting deadline
--------------------------------------------------------------------------------

- Nasdaq notified Artelo on Jan 14, 2026 of non-compliance with the Annual Meeting Rule (5620(a)).
- Annual meeting adjourned from Dec 31, 2025 to Jan 30, 2026 due to insufficient quorum.
- Non-compliance is an additional basis for delisting; company already under equity deficiency (Rule 5550(b)(1)).
- Company will take measures to regain compliance; stock continues trading pending hearing panel decision.
- No assurance that appeal of equity deficiency delisting determination will succeed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000109/0001640334-26-000109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000109/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-000109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer